JP4208464B2 - ナフチリジン−3−カルボン酸誘導体の製造法 - Google Patents

ナフチリジン−3−カルボン酸誘導体の製造法 Download PDF

Info

Publication number
JP4208464B2
JP4208464B2 JP2001522225A JP2001522225A JP4208464B2 JP 4208464 B2 JP4208464 B2 JP 4208464B2 JP 2001522225 A JP2001522225 A JP 2001522225A JP 2001522225 A JP2001522225 A JP 2001522225A JP 4208464 B2 JP4208464 B2 JP 4208464B2
Authority
JP
Japan
Prior art keywords
formula
naphthyridine
carboxylic acid
compound represented
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001522225A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003508532A (ja
JP2003508532A5 (enExample
Inventor
チョ・スンウォク
チョイ・フン
ジョン・デイビッド・ヘイラー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Corp
SB Pharmco Puerto Rico Inc
Original Assignee
LG Chem Investment Co Ltd
SB Pharmco Puerto Rico Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Chem Investment Co Ltd, SB Pharmco Puerto Rico Inc filed Critical LG Chem Investment Co Ltd
Publication of JP2003508532A publication Critical patent/JP2003508532A/ja
Publication of JP2003508532A5 publication Critical patent/JP2003508532A5/ja
Application granted granted Critical
Publication of JP4208464B2 publication Critical patent/JP4208464B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2001522225A 1999-09-03 2000-09-01 ナフチリジン−3−カルボン酸誘導体の製造法 Expired - Fee Related JP4208464B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9920917.3A GB9920917D0 (en) 1999-09-03 1999-09-03 Novel process
GB9920917.3 1999-09-03
PCT/GB2000/003366 WO2001018002A1 (en) 1999-09-03 2000-09-01 Process for production of naphthyridine-3-carboxylic acid derivatives

Publications (3)

Publication Number Publication Date
JP2003508532A JP2003508532A (ja) 2003-03-04
JP2003508532A5 JP2003508532A5 (enExample) 2005-12-22
JP4208464B2 true JP4208464B2 (ja) 2009-01-14

Family

ID=10860353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001522225A Expired - Fee Related JP4208464B2 (ja) 1999-09-03 2000-09-01 ナフチリジン−3−カルボン酸誘導体の製造法

Country Status (23)

Country Link
US (1) US7232907B2 (enExample)
EP (1) EP1214321B1 (enExample)
JP (1) JP4208464B2 (enExample)
KR (1) KR100724311B1 (enExample)
CN (1) CN1275963C (enExample)
AR (1) AR029002A1 (enExample)
AT (1) ATE271050T1 (enExample)
AU (1) AU773722B2 (enExample)
BR (1) BRPI0013751B8 (enExample)
CA (1) CA2383753C (enExample)
CO (1) CO5470281A1 (enExample)
DE (1) DE60012196T2 (enExample)
DK (1) DK1214321T3 (enExample)
ES (1) ES2223574T3 (enExample)
GB (1) GB9920917D0 (enExample)
HK (1) HK1047093B (enExample)
MX (1) MXPA02002355A (enExample)
MY (1) MY125309A (enExample)
PT (1) PT1214321E (enExample)
SI (1) SI1214321T1 (enExample)
TW (1) TWI274753B (enExample)
WO (1) WO2001018002A1 (enExample)
ZA (1) ZA200201781B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
WO2003011450A1 (en) 2001-08-02 2003-02-13 Lg Life Sciences Limited Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
WO2006134431A1 (en) * 2005-05-03 2006-12-21 Ranbaxy Laboratories Limited Formate salt of gemifloxacin
EP2159225A1 (en) 2005-06-15 2010-03-03 Hetero Drugs Limited Gemifloxacin process and polymorphs
US20100076193A1 (en) * 2006-10-31 2010-03-25 Chandrasekaran Ramasubbu process for the preparation of gemifloxacin

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (enExample) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のp‐トルエンスルホン酸塩
IE66202B1 (en) 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
EP0541086A1 (en) 1991-11-08 1993-05-12 Kaken Pharmaceutical Co., Ltd. Antibacterial 6-fluoro-quinolones having an oxime group on the substituent in position 7
JPH0673056A (ja) 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
DK0688772T3 (da) * 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
RU2140910C1 (ru) 1995-08-11 1999-11-10 Пфайзер Инк. Тригидрат метансульфоната (1s,2s)-1-(4-гидроксифенил)-2-(4-гидрокси-4- фенилпиперидин-1-ил)-1-пропанола
BR9708336A (pt) 1996-03-29 1999-08-03 Smithkline Beecham Corp Diidrato de eprosartan e processo para sua produção e formulação
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
JP2002516308A (ja) 1998-05-29 2002-06-04 ファルマシア・アンド・アップジョン・カンパニー 3−[(1’−n−メチルアミノ)エチル−n−ベンジル]ピロリジンモノメタンスルホネート
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
PT1223935E (pt) 1999-06-29 2008-04-03 Lg Life Sciences Ltd Utilização de compostos de gemifloxacina contra bactérias
AU6947900A (en) 1999-09-01 2001-03-26 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
AU7709400A (en) 1999-09-22 2001-04-24 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
KR20010091379A (ko) 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko) 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-z-메톡시이미노피롤리딘의 신규 제조방법

Also Published As

Publication number Publication date
MXPA02002355A (es) 2004-07-16
GB9920917D0 (en) 1999-11-10
CA2383753A1 (en) 2001-03-15
KR100724311B1 (ko) 2007-06-04
TWI274753B (en) 2007-03-01
DK1214321T3 (da) 2004-10-25
CN1377350A (zh) 2002-10-30
ATE271050T1 (de) 2004-07-15
AU773722B2 (en) 2004-06-03
EP1214321A1 (en) 2002-06-19
CA2383753C (en) 2011-06-28
PT1214321E (pt) 2004-10-29
ES2223574T3 (es) 2005-03-01
EP1214321B1 (en) 2004-07-14
HK1047093A1 (en) 2003-02-07
JP2003508532A (ja) 2003-03-04
DE60012196T2 (de) 2005-08-18
ZA200201781B (en) 2003-06-25
BR0013751A (pt) 2002-05-07
KR20020041421A (ko) 2002-06-01
SI1214321T1 (en) 2004-12-31
US7232907B2 (en) 2007-06-19
US20050176961A1 (en) 2005-08-11
HK1047093B (en) 2005-05-27
BR0013751B1 (pt) 2013-02-05
CO5470281A1 (es) 2004-12-30
AU7019700A (en) 2001-04-10
WO2001018002A1 (en) 2001-03-15
DE60012196D1 (de) 2004-08-19
BRPI0013751B8 (pt) 2021-05-25
AR029002A1 (es) 2003-06-04
MY125309A (en) 2006-07-31
CN1275963C (zh) 2006-09-20

Similar Documents

Publication Publication Date Title
JP2000512994A (ja) テトラヒドロイミダゾキノリンアミン調製方法
IE913307A1 (en) Process for the preparation of imidazo[4,5-c]quinolin-4-amines
CA2493227A1 (en) Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates
JP4208464B2 (ja) ナフチリジン−3−カルボン酸誘導体の製造法
JP4208463B2 (ja) キノロンカルボン酸誘導体の製造に関する中間体
RU2049778C1 (ru) Способ получения производного 8-хлорхинолона
KR0153530B1 (ko) 락탐 유도체의 제조 방법
JP2552101B2 (ja) 新規ピリドンカルボン酸誘導体及びその調製方法
WO2002024696A1 (en) Process for producing tricyclic fused heterocyclic derivative
KR20030081762A (ko) 플루오로피롤리딘 치환체를 포함하는 퀴놀린 카르복실산유도체 및 그의 제조방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040915

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080527

A256 Written notification of co-pending application filed on the same date by different applicants

Free format text: JAPANESE INTERMEDIATE CODE: A2516

Effective date: 20080527

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080827

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080924

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081021

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111031

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111031

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121031

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121031

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131031

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees